About BioPhero
BioPhero is a company based in Copenhagen (Denmark) founded in 2018 by Carina Holkenbrink. BioPhero has raised $21.75 million across 6 funding rounds from investors including European Union, DCVC and Novo Holdings. The company has 14 employees as of June 30, 2020. BioPhero operates in a competitive market with competitors including Provivi, Oxitec, PheroSyn, Barrix Agro Sciences and Pheronym, among others.
- Headquarter Copenhagen, Denmark
- Employees 14 as on 30 Jun, 2020
- Founders Carina Holkenbrink
- Stage Minicorn
-
Sectors
Chemicals & MaterialsAgriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biophero Aps
-
Annual Revenue
Not available
-
Net Profit
-$1.39 M (USD)-92as on Dec 31, 2020
-
EBITDA
Not available
-
Total Equity Funding
$21.75 M (USD)
in 6 rounds
-
Latest Funding Round
$17 M (USD), Series A
Feb 12, 2021
-
Investors
European Union
& 5 more
-
Employee Count
14
as on Jun 30, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of BioPhero
Unlock access to complete
Unlock access to complete
Software Development Team
73 people
Leadership Team
53 people
Finance and Accounting
43 people
Sales and Marketing
34 people
Human Resources and Administration
30 people
Global Team
15 people
Senior Team
15 people
Product Management Team
14 people
Unlock access to complete
Funding Insights of BioPhero
BioPhero has successfully raised a total of $21.75M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $17 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BioPhero
BioPhero has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, DCVC and Novo Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Private equity and venture capital fund focused on the healthcare sector
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for BioPhero
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioPhero
Investment portfolio details for BioPhero
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioPhero
Detailed financials for BioPhero
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biophero Comparisons
Peer comparison for BioPhero
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioPhero
BioPhero operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Provivi, Oxitec, PheroSyn, Barrix Agro Sciences and Pheronym, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of biocatalyst and fermentation technology for pest control
|
|
| Locked | Locked | Locked |
Genetically modified insects are developed to suppress pest populations.
|
|
| Locked | Locked | Locked |
Provider of pheromone-based integrated pest management solution
|
|
| Locked | Locked | Locked |
Manufacturer of pheromone traps and plant management solutions
|
|
| Locked | Locked | Locked |
Developer of nematode pheromone-based crop protection products
|
Detailed competitors of BioPhero
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biophero
Complete news archive for BioPhero
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioPhero
BioPhero was founded in 2018.
BioPhero is headquartered in Copenhagen, Denmark.
Kristian Ebbensgaard is the current CEO of BioPhero.
BioPhero is a funded company, having raised a total of $21.75M across 6 funding rounds to date.
As of Jun 30, 2020, the latest employee count at BioPhero is 14.
BioPhero was established in 2018 in Copenhagen, Denmark. Insect pheromones are manufactured via a fermentation process involving yeasts, targeting pest control in agriculture. Solutions are provided for specialty crops including apples and grapes. Operations focus on the biotechnology sector, with headquarters located in Lyngby, supporting sustainable pest management practices across Europe.
BioPhero has 6 investors. Key investors include European Union, DCVC, Novo Holdings, FMC Ventures, and Syngenta Group.
The valuation of BioPhero is $21.4M as of Feb 2021.